Inhibition of the pathway regulated by VEGF, FGF, CTGF, PDGF, and TGF-β has been suggested to provide novel therapeutic approaches for the treatment of fibrosis associated with chronic lung diseases. Here, TGFB1 is linked to chronic lung disease.